New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic

New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic

Marco Caminati,1,2 Diego Bagnasco,3 Rachele Vaia,2 Gianenrico Senna11Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy; 2Department of Medicine, School of Specialization in Allergy and Clinical Immunology, University of Verona, Verona, Italy; 3Allergy & Respiratory Di...

Full description

Bibliographic Details
Main Authors: Caminati M, Bagnasco D, Vaia R, Senna G
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:Biologics: Targets & Therapy
Subjects:
Benralizumab efficacy
benralizumab safety
benralizumab mechanism of action
anti IL-5 mAbs
severe asthma
eosinophilic asthma
Online Access:https://www.dovepress.com/new-horizons-for-the-treatment-of-severe-eosinophilic-asthma-benralizu-peer-reviewed-article-BTT

Internet

https://www.dovepress.com/new-horizons-for-the-treatment-of-severe-eosinophilic-asthma-benralizu-peer-reviewed-article-BTT

Similar Items